These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
701 related articles for article (PubMed ID: 25745075)
1. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study. Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075 [TBL] [Abstract][Full Text] [Related]
2. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT. Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690 [TBL] [Abstract][Full Text] [Related]
3. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820 [TBL] [Abstract][Full Text] [Related]
4. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial. Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699 [TBL] [Abstract][Full Text] [Related]
6. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study. Kutyifa V; Daubert JP; Schuger C; Goldenberg I; Klein H; Aktas MK; McNitt S; Stockburger M; Merkely B; Zareba W; Moss AJ Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e001965. PubMed ID: 26743237 [TBL] [Abstract][Full Text] [Related]
7. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). Barsheshet A; Wang PJ; Moss AJ; Solomon SD; Al-Ahmad A; McNitt S; Foster E; Huang DT; Klein HU; Zareba W; Eldar M; Goldenberg I J Am Coll Cardiol; 2011 Jun; 57(24):2416-23. PubMed ID: 21658562 [TBL] [Abstract][Full Text] [Related]
8. Dyssynchrony and the risk of ventricular arrhythmias. Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010 [TBL] [Abstract][Full Text] [Related]
9. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954 [TBL] [Abstract][Full Text] [Related]
10. Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events. Szepietowska B; Polonsky B; Sherazi S; Biton Y; Kutyifa V; McNitt S; Aktas M; Moss AJ; Zareba W Cardiovasc Diabetol; 2016 Jul; 15():93. PubMed ID: 27388610 [TBL] [Abstract][Full Text] [Related]
11. Reduced risk of life-threatening ventricular tachyarrhythmias with cardiac resynchronization therapy: relationship to left ventricular ejection fraction. Kutyifa V; Moss AJ; Solomon SD; McNitt S; Aktas MK; Barsheshet A; Merkely B; Zareba W; Goldenberg I Eur J Heart Fail; 2015 Sep; 17(9):971-8. PubMed ID: 26173635 [TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT. Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489 [TBL] [Abstract][Full Text] [Related]
13. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077 [TBL] [Abstract][Full Text] [Related]
14. QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients. Goldenberg I; Aktas MK; Zareba W; Tsu-Chau Huang D; Rosero SZ; Younis A; McNitt S; Stockburger M; Steinberg JS; Buttar RS; Merkely B; Kutyifa V JACC Clin Electrophysiol; 2024 Jan; 10(1):16-26. PubMed ID: 38032575 [TBL] [Abstract][Full Text] [Related]
15. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial. Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322 [TBL] [Abstract][Full Text] [Related]
16. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490 [TBL] [Abstract][Full Text] [Related]
17. The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT. Mittal S; Aktas MK; Moss AJ; McNitt S; Kutyifa V; Steinberg JS; Zareba W J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1082-7. PubMed ID: 24862906 [TBL] [Abstract][Full Text] [Related]
18. Regional Longitudinal Deformation Improves Prediction of Ventricular Tachyarrhythmias in Patients With Heart Failure With Reduced Ejection Fraction: A MADIT-CRT Substudy (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). Biering-Sørensen T; Knappe D; Pouleur AC; Claggett B; Wang PJ; Moss AJ; Solomon SD; Kutyifa V Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28003221 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ; Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819 [TBL] [Abstract][Full Text] [Related]
20. Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Aktas MK; Goldenberg I; Moss AJ; Huang DT; Kutyifa V; Wang PJ; Brenyo A; McNitt S; Zareba W; Barsheshet A Am J Cardiol; 2014 Dec; 114(12):1855-60. PubMed ID: 25438913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]